Stock PMCB PHARMACYTE BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart PharmaCyte Biotech, Inc.

Equities

PMCB

US71715X2036

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-15 pm EDT 		5-day change 1st Jan Change
2.09 USD -1.20% Intraday chart for PharmaCyte Biotech, Inc. -3.24% -3.24%
Mar. 18 PharmaCyte Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
2023 PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PHARMACYTE BIOTECH, INC. Stock PharmaCyte Biotech, Inc.
 17.67M - - - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 709B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
 367B
MERCK & CO., INC. Stock Merck & Co., Inc.
 334B
ABBVIE INC. Stock AbbVie Inc.
 289B
  1. Stock Market
  2. Equities
  3. PMCB Stock
  4. Charts PharmaCyte Biotech, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW